 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
576 Swan Street 3121 Richmond VIC
Australia
|
|
Portrait HealthLinx uses biomarkers to develop best practice diagnostics that detect and monitor diseases. First commercial targets are: ovarian cancer diagnostic (OvPlex) targeting US$250m pa market; and pregnancy diagnostic. This would be used in a woman’s first prenatal visit to identify whether she is at high risk of having complications during pregnancy. Currently there is no product on the market which identifies complications in early stages of pregnancy.
Industrial Sectors
Additional information
HealthLinx Limited Richmond VIC , Australia
News
|
|
|
|
|
|